Health Publications

Barcelona conference daily news links

AIDS Treatment News, August 9, 2002

The next-day reporting from the conference had to focus on individual meetings instead of broader perspectives. Still, some of these reports may be the best source available for particular information you need. You can use these links to read quickly through the dozens of titles, to find what is important for you.

Note: Web sites often get reorganized, so some of these links may not work when you try them. In that case, go to the home page of the site (usually the part of the address through the .com or .org), and look for the reports from there.

The annotations in brackets below are our own.

* Medscape [information for medical professionals and patients]

http://www.medscape.com/viewprogram/l980 also see

http://www.medscape.com/pages/editorial/newsbeats/aids

* Kaiser Family Foundation [general conference news widely syndicated on other sites]

http://www.kaisernetwork.org/aids2002/

* Health & Development Networks [important international coverage]

http://www.hdnet.org/home2.htm

* The Body [focus on new drugs and other medical news]

http://www.thebody.com/confs/aids2002/aids2002.html

* International Association of Physicians in AIDS Care (IAPAC), http://www.iapac.org/ [Choose IAPAC AIDScan for their daily newsletter on the conference.]

* HIV and Hepatitis.com [many news reports]

http://www.hivandhepatitis.com

* National AIDS Treatment Advocacy Project [occasional medical articles, also strong on hepatitis]

http://www.natap.org/

* For a short (6 pages single spaced) overview of the conference, focusing on medical information that will affect patient care over the next several years, see "A Roundup of Barcelona" by Pablo Tebas, available at: http://www.thebody.com/confs/aids2002/tebas10.html.> From the Roundup: "The science--at least the clinical part--was very good this time, much better than in Durban or in Retrovirus this year. Major trials like ACTG 384, INITIO, Gilead 903, and the TORO trials were presented during the Barcelona conference. These trials will mark the next months if not years of HIV treatment."